Geron Corp (GERN) stock
GERNNasdaqPharmaceutical PreparationsFiscal year ends December 31
$0.87−0.04 (-4.63%)
Close on Nov 20, 2026Market cap $559.40MP/E –Yield –
Geron free cash flow
Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.
Geron's free cash flow for the twelve months ending Dec 31, 2024 was -$219.30M. For fiscal 2024 it was -$219.30M. The highest annual figure on record is $9.22M in fiscal 2014.
Annual free cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | -$219.30M | – |
| FY2023 | Dec 31, 2023 | -$168.57M | – |
| FY2022 | Dec 31, 2022 | -$127.81M | – |
| FY2021 | Dec 31, 2021 | -$95.76M | – |
| FY2020 | Dec 31, 2020 | -$67.05M | – |
| FY2019 | Dec 31, 2019 | -$44.24M | – |
| FY2018 | Dec 31, 2018 | -$21.03M | – |
| FY2016 | Dec 31, 2016 | -$18.43M | – |
| FY2015 | Dec 31, 2015 | -$24.29M | -363.4% |
| FY2014 | Dec 31, 2014 | $9.22M | – |
| FY2013 | Dec 31, 2013 | -$36.68M | – |
| FY2012 | Dec 31, 2012 | -$56.01M | – |
| FY2011 | Dec 31, 2011 | -$63.00M | – |
| FY2010 | Dec 31, 2010 | -$45.13M | – |
| FY2009 | Dec 31, 2009 | -$44.81M | – |
Quarterly free cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2024 | Dec 31, 2024 | -$43.80M | – |
| Q3 FY2024 | Sep 30, 2024 | -$58.94M | – |
| Q2 FY2024 | Jun 30, 2024 | -$53.68M | – |
| Q1 FY2024 | Mar 31, 2024 | -$62.87M | – |
| Q4 FY2023 | Dec 31, 2023 | -$41.00M | – |
| Q3 FY2023 | Sep 30, 2023 | -$51.03M | – |
| Q2 FY2023 | Jun 30, 2023 | -$29.80M | – |
| Q1 FY2023 | Mar 31, 2023 | -$46.74M | – |
| Q4 FY2022 | Dec 31, 2022 | -$35.32M | – |
| Q3 FY2022 | Sep 30, 2022 | -$29.75M | – |
| Q2 FY2022 | Jun 30, 2022 | -$28.71M | – |
| Q1 FY2022 | Mar 31, 2022 | -$34.02M | – |
| Q4 FY2021 | Dec 31, 2021 | -$22.27M | – |
| Q3 FY2021 | Sep 30, 2021 | -$22.93M | – |
| Q2 FY2021 | Jun 30, 2021 | -$17.81M | – |
| Q1 FY2021 | Mar 31, 2021 | -$32.74M | – |
| Q4 FY2020 | Dec 31, 2020 | -$12.63M | – |
| Q3 FY2020 | Sep 30, 2020 | -$15.45M | – |
| Q2 FY2020 | Jun 30, 2020 | -$12.59M | – |
| Q1 FY2020 | Mar 31, 2020 | -$26.39M | – |
| Q4 FY2019 | Dec 31, 2019 | -$10.46M | – |
| Q3 FY2019 | Sep 30, 2019 | -$12.24M | – |
| Q2 FY2019 | Jun 30, 2019 | -$8.77M | – |
| Q1 FY2019 | Mar 31, 2019 | -$12.78M | – |
| Q4 FY2018 | Dec 31, 2018 | -$3.02M | – |
| Q4 FY2016 | Dec 31, 2016 | -$633.00K | – |
| Q3 FY2016 | Sep 30, 2016 | -$6.55M | – |
See a number that looks wrong?